In addition to anorexia, fat and muscle tissue wasting, psychological distress, lower tolerance to chemotherapy, and a poor quality of life, cachexia causes profound metabolic dysregulation in cancer patients that affects multiple organs. Here, for the first time, we have characterized metabolic changes in the spleen, liver, pancreas, lung, heart and kidney induced by pancreatic cancer xenografts to expand our understanding of the metabolic dysregulation caused by cachexia. These results highlight the systemic changes in metabolism that occur with cancer and with cancer induced cachexia that may lead to the development of early biomarkers as well to metabolic treatment strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords